Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Elshamaa, Manal F ^a   Sabry, Samar M ^b   Bazaraa, Hafez M ^b   Koura, Hala M ^a   Elghoroury, Eman A ^a   Kantoush, Nagwa A ^a   Thabet, Eman H ^a   Abd El Haleem, Dalia A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

angiotensin II type one receptor; angiotensin converting enzyme; DNA polymorphisms; end stage renal disease, Children

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA;

ACE GENE; ALLELE; ANGIOTENSIN II TYPE 1 RECEPTOR GENE; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; RECEPTOR GENE; SCHOOL CHILD; TREATMENT PLANNING;

EID: 80052026950     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-20     Document Type: Article

References (49)

1. Blood pressure control-special role of the kidneys and body fluids. Guyton AC, Science 1991 252 1813 1816 10.1126/science.2063193 2063193 (Pubitemid 21917099)
2. Conversion of Angiotensin I to Angiotensin II. Ng KKF, Vane JR, Nature 1967 216 762 10.1038/216762a0 4294626
3. The mechanism of pressure naturiuresis. Firth JD, Raine AEG, Ledingham JGG, J Hypertens 1990 8 97 103 10.1097/00004872-199002000-00001 2162885 (Pubitemid 20167760)
4. Analysis of polymorphism in Renin Angiotensin System and other related genes in South Indian chronic kidney disease patients. Anbazhagan K, Sampathkumar K, Ramakrishnan M, Gomathi P, Gomathi S, Selvam GS, Clinica Chimica Acta 2009 406 108 112 10.1016/j.cca.2009.06.003
5. Hypertensive renal damage: insights from animal models and clinical relevance. Griffin KA, Bidani AK, Curr Hypertens Res 2004 6 145 153 10.1007/s11906-004-0091-8 (Pubitemid 39359556)
6. Nondiabetic kidney diseases. Levey AS, N Engl J Med 2002 347 1505 1511 10.1056/NEJMcp013462 12421894 (Pubitemid 35257591)
7. Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1R and ecNOS. El-Essawy AB, Berthoux P, Cecillon S, Deprele c, Thibaudin D, De Fillppis JP, Alamartine E, Berthoux F, Clin Nephrol 2002 57 192 200 11926202 (Pubitemid 34213657)
8. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. Becker BN, Himmelfarb J, Heinrich WL, Hakim RM, J Am Soc Nephrol 1997 8 475 486 9071717 (Pubitemid 127454184)
9. Polymorphism of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new finding and meta-analysis of data. Mondry A, Loh M, Liu P, Zhu AL, Nagel M, BMC Nephrol 2005 6 1 10.1186/1471-2369-6-1 15642127 (Pubitemid 40317991)
10. The role of rennin-angiotensin-aldosterone system in chronic kidney diseases. Vaughan C, Expert Rev Cardiovac Ther 2003 1 227 235
11. ACE genotype and ACE inhibitor response in Kidney disease: a perspective. Mayer G, Am J Kidney Dis 2002 40 227 235 10.1053/ajkd.2002.34489 12148094 (Pubitemid 34827639)
12. Safety of telmisartan in patients with arterial hypertension: an open label, observational study. Michel MC, Bohner H, Koster J, Schafers RF, Hemann U, Drug Safety 2004 27 334 335
13. Renoprotective properties of ACE inhibition in non-diabetic nephropathies with nonnephrotic proteinuria. Ruggenenti P, Perna A, Gherardi G, Lancet 1999 354 359 364 10.1016/S0140-6736(98)10363-X 10437863 (Pubitemid 29355751)
14. Significance of genetic polymorphisms of the renin-angiotensin- aldosterone system in cardiovascular and renal disease. Rudnicki M, Mayer G, Pharmacogenomics 2009 10 463 476 10.2217/14622416.10.3.463 19290794
15. Angiotensin-converting enzyme polymorphism gene and evolution of nephropathy to end-stage renal disease. Ortiz MA, De Prado A, Donate T, Nephrol 2003 8 171 176 10.1046/j.1440-1797.2003.00165.x (Pubitemid 36995086)
16. The impact of rennin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Miller JA, Scholey JW, Curr Opin Nephrol Hypertension 2004 13 101 116 10.1097/00041552-200401000-00014 (Pubitemid 39069905)
17. Enhanced response of blood pressure, renal function and aldosterone to angiotensin I in DD genotype are blunted by low sodium intake. Van Der Kleij FGH, De Jong PE, Henning RH, Zeeuw DD, Navis G, J Am Soc Nephrol 2002 13 1025 1033 11912262 (Pubitemid 34274099)
18. Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function-a single-center experience. Siekierka-H M, Kuhr N, Willers R, Ivens K, Grabensee B, Mondry A, Loh MCS, Rump LC, Blume C, Clinical Transplant 2009 23 5 606 615 10.1111/j.1399-0012.2009. 01033.x
19. Effect of deletion polymorphism of angiotensin converting enzyme on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. Parving HH, Jacobson P, Tarnow L, Rossing P, Poirier O, Cambien F, BMJ 1996 313 591 594 8806248 (Pubitemid 26293643)
20. Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms. Nakayama Y, Nonoguchi H, Kohda Y, Inoue H, Memetimin H, Izumi Y, Tomita K, Nephron Clin Pract 2009 111 240 246 10.1159/000209150 19293592
21. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Kim S, Iwao W, Pharmacol Rev 2000 52 11 34 10699153 (Pubitemid 30127593)
22. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 1 S266 11904577
23. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Adams JE, Schechiman KB, Landt, et al. Clin Chem 1994 40 129 135
24. Function of CRP. Duclos TW, Ann Med 2000 32 274 278 10.3109/ 07853890009011772 10852144
25. Effect of drugs on clinical lab. Young DS, Test AACC press 5 2000
26. Polymorphism of renin-angiotensin system genes in dialysis patients - association with cerebrovascular disease. Losito A, Kalidas K, Santoni S, Ceccarelli L, Jeffery S, Nephrolo Dial Transplant 2002 17 2184 2188 10.1093/ndt/17.12.2184 (Pubitemid 35446676)
27. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Devereux R, Alonso D, Lutas E, Gottlieb G, Campo E, Sachs I, Reichek N, The Am Journal of Cardiol 1986 57 450 458 10.1016/0002-9149(86) 90771-X (Pubitemid 16119719)
28. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. De Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH, J Am Coll Cardiol 1992 20 1251 60 10.1016/0735-1097(92)90385-Z 1401629
29. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH, J Am Coll Cardiol 1995 25 1056 62 10.1016/0735-1097(94)00540-7 7897116
30. The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. Mallamaci F, Zuccala A, Zoccali C, et al. Am J Hypertens 2000 13 433 437 10.1016/S0895-7061(99)00195-8 10821348 (Pubitemid 30312666)
31. Angiotensin I converting enzyme gene polymorphism in non-diabetic renal disease. Samuelsson O, Attman PO, Larsson R, et al. Nephrol Dial Transplant 2000 5 81 86
32. Genetic risk factors for renal failure among north Indian ESRD patients. Tripathi G, Sharma RK, Baburaj VP, Sankhwar SN, Jafar T, Agrawal S, Clin Biochem 2008 41 525 31 10.1016/j.clinbiochem.2008.01.009 18242170
33. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients. Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN, Ren Fail 2009 31 196 200 10.1080/08860220802669826 19288324
34. Angiotensin-converting enzyme gene polymorphism and the progression rate of focal segmental glomerulosclerosis in Iranian children. Gheissari A, Salehi M, Dastjerdi SB, Jahangiri M, Hooman N, Otookesh H, Merikhipour A, Ajir A, Foroughmand A, Khatami S, Shahidi S, Atapour A, Seirafian S, Naeini AE, Nephrology (Carlton) 2008 13 708 11 10.1111/j.1440-1797.2008.00990.x
35. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Egyptian patients with myocardial infarction. Settin A, ElBaz R, Abbas A, Abd-Al-Samad A, Noaman A, Journal of Renin-Angiotensin-Aldosterone System 2009 10 96 101 10.1177/1470320309105198
36. Angiotensin-converting enzyme gene polymorphism in Egyptian patients with diabetic nephropathy. Ketat A, Diab I, Gad M, Elaghoury A A, Alexandria bulletin Fac Med 2006 42 445 450
37. ACE gene polymorphism in Egyptian children with idiopathic nephrotic syndrome. Fahmy ME, Fattouh AM, Hegazy RA, Essawi ML, Bratisl Lek Listy 2008 109 298 301 18792483
38. Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children. Morsy MM, Abdelaziz NA, Boghdady AM, Ahmed H, Abu Elfadl EM, Ismail MA, Rheumatol Int 2009 31 17 21 19847428
39. Influence of the I/D polymorphism of the angiotensin- converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Redon J, Chaves FJ, Liao Y, Pascual JM, Rovira E, armengod ME, Cooper RS, Hypertension 2000 35 490 495 10642347 (Pubitemid 30054222)
40. Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease. Buraczynska M, Ksiazek P, Zaluska W, Spasiewicz D, Nowicka T, Ksiazek A, Nephron 2002 92 51 55 10.1159/000064455 12187084 (Pubitemid 34983875)
41. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol PP, Soubrier F, Hypertens 1994 24 63 69 (Pubitemid 24195405)
42. Association between a Deletion Polymorphism of the Angiotensin- Converting-Enzyme Gene and Left Ventricular Hypertrophy. Schunkert H, Hense H-W, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger G, N Engl J Med 1994 330 1634 163 10.1056/NEJM199406093302302 8177269 (Pubitemid 24166863)
43. ACE and AGTR1 Polymorphisms and Left Ventricular Hypertrophy. Di Mauro M, Izzicupo P, Santarelli F, Falone S, Pennelli A, Amicarelli F, Calafiore AM, Di Baldassarre A, Gallina S, Endurance Athletes Medicine & Science in Sports & Exercise 2010 42 915 921 21873552
44. The ACE/DD genotype is associated with the extent of exercise-induced left ventricular growth in endurance athletes. Hernández D, de la Rosa A, Barragán A, Barrios Y, Salido E, Torres A, Martín B, Laynez I, Duque A, De Vera A, Lorenzo V, González A, J Am Coll Cardiol 2003 42 527 32 10.1016/S0735-1097(03)00642-9 12906984 (Pubitemid 36951722)
45. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Takami S, Katsuya T, Rakugi H, Sato N, Nakata Y, Kamitani A, Miki T, Higaki J, Ogihara T, Am J Hypertens 1998 11 316 321 10.1016/S0895-7061(97)00457-3 9544872 (Pubitemid 28186743)
46. Cardiovascular disease as a late complication of end-stage renal disease in children. Groothoff JW, Lilien MR, Nicole CAJ, van de Kar, Wolff ED, Davin JC, Pediatric Nephrology 2005 20 374 379 10.1007/s00467-004-1624-8 15549413 (Pubitemid 40309946)
47. Cardiac and Vascular Adaptation in Pediatric Patients with Chronic Kidney Disease: Role of Calcium-Phosphorus Metabolism. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR, Am Soc Nephrol 2005 16 2796 2803 10.1681/ASN.2005030291
48. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Martin GS, Becker BN, Schulman G, Nephrol Dial Transplant 1998 13 1709 1712 10.1093/ndt/13.7.1709 9681716 (Pubitemid 28306799)
49. Immunological basis of inflammation in dialysis. Amore A, Coppo R, Nephrol Dial Transplant 2002 17 16 24 12386276 (Pubitemid 34918874)